Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsLymphocyte Activation Gene 3 Protein
Dr. Amy M. Weise, DO
NPI1245448042PAC ID9032218425
- Medicare services, 2024
- 373
- Medicare patients, 2024
- 89
- Part D claims, 2024
- 596
- Publications
- 21
- Clinical trials
- 12
- Practice address
- 2799 W Grand Blvd, Detroit, MI 48202
- Practice phone
- Call (313) 916-2600
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Weise's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Amy M. Weise is a medical oncologist in Detroit, Michigan
Dr. Weise practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.
Dr. Weise's NPI, 1245448042, was assigned on May 18, 2007. Dr. Weise graduated from Michigan State University College of Osteopathic Medicine in 1996. Dr. Weise holds Michigan license 5101016156.
NPI and contact details
- NPI
- 1245448042NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9032218425
- NPI enumeration date
- May 18, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (313) 916-2600
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Amy M. Weise practices at Henry Ford Hospital in Detroit, Michigan
Dr. Weise's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.
- Henry Ford Hospital2799 W Grand Blvd, Detroit, MI 48202 · Wayne CountyPhone(313) 916-2600
Source: Dmand AI Affiliation Data
Dr. Amy M. Weise is affiliated with 5 sites of care and 3 medical groups
Dr. Weise's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Weise is also affiliated with Karmanos Cancer Center. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Weise to 3 more hospitals and 2 medical groups, each named with a free account.
Karmanos Cancer CenterHenry Ford Health3 hospitalsNames with a free account2 medical groupsNames with a free account
See all 8 affiliations for Dr. WeiseSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Amy M. Weise's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weise practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Henry Ford Hospital | Available with a free account |
| +4 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Weise practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Henry Ford Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Amy M. Weise is one of 171 medical oncologists in Michigan
Medical oncology is Dr. Weise's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Weise is licensed in Michigan.
Specialties and state licenses
- Medical oncology, MichiganPrimary
Medical oncologists near Dr. Weise
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
171medical oncologists in Michigan29medical oncologists in Detroit15medical oncologists at Henry Ford Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Amy M. Weise billed Medicare for 373 services in 2024
CMS data shows 373 Medicare services from Dr. Weise across 4 procedure codes in 2024, for 89 Medicare patients. Medicare paid $23,678 for them.
Medicare services, 2024373
Medicare patients89
Paid by Medicare$23,678
Procedure codes4
Dr. Weise's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3352024: 22533%
- Other services
- 2023: 02024: 148
Where Dr. Weise's Medicare services took place, 2024
- In an office12333%
- In a facility25067%
Dr. Weise compared with the Michigan median for medical oncologists, 2024
- Dr. Weise
- Michigan median
- Medicare services
- 373vs 364Close to median
- Medicare patients
- 89vs 13635% below
- Part D claims
- 392vs 33417% above
Medians across 165 medical oncologists in Michigan with Dmand AI profiles that report each measure.
Dr. Weise's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Weise?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Weise and other medical oncologists in Michigan.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Amy M. Weise treated 89 Medicare patients in 2024, average age 72
CMS counts 89 Medicare patients who saw Dr. Weise in 2024. The largest group is 65 to 74, with 44 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Weise's median patient age at 68, with 63% women.
Medicare patients, 202489
Average age72
Average risk score2.78
Also on Medicaid15%
Dr. Weise's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Weise's Medicare patients by sex, 2024
- Women3944%
- Men5056%
Chronic conditions among Dr. Weise's Medicare patients, 2024
- High blood pressure73%
- High cholesterol70%
- Cancer44%
- Arthritis40%
- Anxiety34%
- Chronic kidney disease34%
- Mood disorders31%
- Depression27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Weise's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women63%
- Men37%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Amy M. Weise wrote 596 Medicare Part D claims in 2024
In 2024, Dr. Weise wrote 596 Medicare Part D claims for 97 patients. 73% of them were for generic drugs. CMS names the drug for 392 of them, across 22 drugs with 11 or more claims each, at $1,319,860 in total drug cost. In 2023, CMS named 651 claims across 23 drugs.
Part D claims, 2024596
Drugs named by CMS22
Total drug cost$1.3M
Part D patients97
Dr. Weise's Part D claims by kind of drug, 2024
- Generic435 claims73%
- Brand-name161 claims27%
Dr. Weise's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Weise's Part D claims, 2024
- Opioids19%116 of 596 claims
- Antibiotics4%23 of 596 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6512024: 39240%
Drugs named by CMS: 22 in 2024, 23 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Amy M. Weise offers telehealth to Medicare patients
Dr. Weise accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weise as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find medical oncologists like Dr. Weise by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Amy M. Weise has 21 publications on record
Dmand AI links 21 papers to Dr. Weise, published from 2014 to 2024. 2021 was the busiest year, with 6. The most frequent topics are Antineoplastic Agents, Maximum Tolerated Dose and Skin Neoplasms. Dr. Weise has published most often in J Clin Oncol. Dr. Weise's most frequent co-authors are Joseph Paul Eder, MD, Nilofer Saba Azad, MD and Aditya Bardia, MD.
Papers21
Years published2014 to 2024
Dr. Weise's papers by year, 2014 to 2024
Topics Dr. Weise writes about most
- Antineoplastic Agents
- Maximum Tolerated Dose
- Skin Neoplasms
- Antibodies, Monoclonal, Humanized
- Melanoma
- Neoplasm Metastasis
- Breast Neoplasms
- Carcinoma, Renal Cell
Dr. Weise's most frequent co-authors
- Joseph Paul Eder, MD3 shared papers
- Nilofer Saba Azad, MD2 shared papers
- Aditya Bardia, MD2 shared papers
Recent publications by Dr. Weise
Antineoplastic AgentsLiposarcomaLymphoma
DepsipeptidesHistone Deacetylase InhibitorsMaximum Tolerated Dose
Head and Neck NeoplasmsHeparin, Low-Molecular-WeightLymphoma, Follicular
Clin Breast Cancer
Administration, OralAntineoplastic AgentsBreast Neoplasms
See who Dr. Weise researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Weise works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Amy M. Weise has worked on 12 clinical trials
Dmand AI links Dr. Weise to 12 clinical trials, 3 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Cholangiocarcinoma. SWOG Cancer Research Network sponsors the most, 3. Open Payments lists research payments to Dr. Weise that name 3 trials.
Clinical trials with Dr. Weise by phase
- 3Phase 1: 3 trials
- 2Phase 2: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Weise's trials
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Cholangiocarcinoma
- Carcinoma, Bronchogenic
- Breast Neoplasms, Male
Investigators on the most trials with Dr. Weise
- Manish Kumar Thakur, MD4 shared trials
- Fariborze B. Barhamand, MD3 shared trials
- Ari D. Baron, MD3 shared trials
Recent clinical trials with Dr. Weise
Triple Negative Breast NeoplasmsNeoplasm MetastasisIrinotecan HydrochlorideVeliparib
Stomach NeoplasmsEsophageal NeoplasmsFPA144
The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women With Early Stage Breast Cancer (opens in a new tab)
CompletedPhase 2
Breast NeoplasmsBreast DiseasesSimvastatin
Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors (opens in a new tab)
TerminatedPhase 1
CholangiocarcinomaThyroid NeoplasmsABM-1310Cobimetinib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Amy M. Weise received $14,837 in industry payments from 2017 to 2024
CMS Open Payments shows 33 general payments to Dr. Weise from 15 drug and device companies from 2017 to 2024. Speaker and faculty fees make up the largest share, 57% of the total. Pfizer Inc. paid the most, $8,443. It also lists 95 research payments totaling $57,100 from 2016 to 2025, naming 3 clinical trials.
General payments to Dr. Weise by program year, 2017 to 2024
General payments to Dr. Weise by kind, 2017 to 2024
$14.8Kin total
- Speaker and faculty fees$8,43057%
- Travel and lodging$3,46823%
- Honoraria$2,30016%
- Food and beverage$5334%
- Education$1051%
Companies that paid Dr. Weise the most, 2017 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Amy M. Weise graduated from Michigan State University College of Osteopathic Medicine
Dr. Weise graduated from Michigan State University College of Osteopathic Medicine in 1996.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Amy M. Weise's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Amy M. Weise
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Amy M. Weise's NPI number?
Dr. Amy M. Weise's NPI number is 1245448042. It was assigned on May 18, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Amy M. Weise?
Dr. Amy M. Weise is a medical oncologist in Detroit, Michigan. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Amy M. Weise practice?
Dr. Weise practices at 2799 W Grand Blvd, Detroit, MI 48202. Dr. Weise's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dmand AI also links Dr. Weise to 3 hospitals and 2 medical groups.
What is Dr. Amy M. Weise's office phone number?
The practice phone on file for Dr. Weise is (313) 916-2600.
What is Dr. Amy M. Weise's medical license number?
Dr. Weise holds Michigan license 5101016156.
Which hospitals is Dr. Amy M. Weise affiliated with?
Dr. Weise practices at Henry Ford Hospital in Detroit, Michigan. Dr. Weise is also affiliated with Karmanos Cancer Center. Dmand AI links Dr. Weise to 3 more hospitals.
What medical group is Dr. Amy M. Weise part of?
Dr. Weise is linked to Henry Ford Health. Dmand AI links Dr. Weise to 2 more medical groups.
Does Dr. Amy M. Weise accept Medicare?
Yes. CMS data shows Dr. Weise billed Medicare for 373 services in 2024, and Dr. Weise accepts Medicare assignment.
Does Dr. Amy M. Weise offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Weise as offering telehealth services.
How many Medicare patients does Dr. Amy M. Weise see?
CMS counts 89 Medicare patients who saw Dr. Weise in 2024, with an average age of 72.
Show 7 more questionsShow fewer questions
What services does Dr. Amy M. Weise bill to Medicare?
In 2024, Dr. Weise's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and office visit, established patient (99214).
Where did Dr. Amy M. Weise go to medical school?
Dr. Weise graduated from Michigan State University College of Osteopathic Medicine in 1996.
What drugs does Dr. Amy M. Weise prescribe most?
In 2024 Medicare Part D data, Dr. Weise's most prescribed drugs by claims were Hydrocodone-Acetaminophen, Gabapentin and Levothyroxine Sodium.
Has Dr. Amy M. Weise received payments from drug or device companies?
CMS Open Payments shows $14,837 in general payments to Dr. Weise from 15 companies from 2017 to 2024. The largest total came from Pfizer Inc.
How long has Dr. Amy M. Weise been practicing?
Dr. Weise graduated from medical school in 1996, 30 years ago.
Does Dr. Amy M. Weise do research?
Dmand AI links 21 publications to Dr. Weise, published from 2014 to 2024. Dr. Weise has worked on 12 clinical trials.
Who does Dr. Amy M. Weise publish with?
Dr. Weise's most frequent co-authors are Joseph Paul Eder, MD (3 shared papers), Nilofer Saba Azad, MD (2 shared papers) and Aditya Bardia, MD (2 shared papers).
Selling to medical oncology practices?
See medical oncologists in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card